CPG - CAPR CPG and AVDL among pre market gainers

October, 11 2021 08:21 AM Crescent Point Energy Corporation

Protagonist Therapeutics (NASDAQ:PTGX) +89% after FDA removes clinical hold on rusfertide program Flexion Therapeutics (NASDAQ:FLXN) +73% Pacira Therapeutics acquires Flexion Therapeutics for $8.50 per share in cash plus one CVR Adamas Pharmaceuticals (NASDAQ:ADMS) +70% Supernus to acquire Adamas in a deal worth up to $850 million Trevi Therapeutics (NASDAQ:TRVI) +30%. Kiromic BioPharma (NASDAQ:KRBP) +18% announces strategic collaboration with Gemelli Teaching Hospital to accelerate the analysis of allogeneic CAR-T Clinical trial candidate alexis ISO-1 in solid cancers EZFill Holdings (NASDAQ:EZFL) +14%. TRACON Pharmaceuticals (NASDAQ:TCON) +9%. Ra Medical Systems (NYSE:RMED) +9%. U.S. Well Services (NASDAQ:USWS) +8%. NanoViricides (NYSE:NNVC) +8% NV-CoV-2 shows broad-spectrum Pan-Coronavirus activity Capricor Therapeutics (NASDAQ:CAPR) +7%. Regis (NYSE:RGS) +7%. Borr Drilling (NYSE:BORR) +7%. Hallador Energy (NASDAQ:HNRG) +6% Shale producers seen ramping up as natural gas prices surge Crescent Point Energy (NYSE:CPG) +6%. Liquidia (NASDAQ:LQDA) +5%. Live Oak Acquisition (NYSE:LOKB) +5%. Alzamend Neuro (NASDAQ:ALZN) +5%. Alibaba Group Holding (NYSE:BABA) +5%. Avadel Pharmaceuticals (NASDAQ:AVDL) +5%.

For further details see:

CAPR, CPG and AVDL among pre market gainers

Company Name:	Crescent Point Energy Corporation
Stock Symbol:	CPG
Market:	NYSE

Twitter